Duisburg, 7 December 2021 – Emergence Therapeutics AG, a biopharmaceutical company developing novel antibody drug conjugates (ADC) for the treatment of cancers with high unmet needs, today announces that it has closed an €87 million series A financing round. The...
Düsseldorf, 14 October 2021 – Abalos Therapeutics today announced an expansion of its Series A financing. This increases the company’s financing volume of the round to €43M ($50M). The expansion round was led by Seventure Partners, with support from...
Duisburg, Marseille, 25 November 2020 – Emergence Therapeutics AG, a European biopharmaceutical company developing novel antibody drug conjugate (ADC) immuno-therapeutics to treat high need cancers, announces that is has closed a Bumped-up Follow-on Seed Round...
